Stanford University researchers examined 18 people ages 54 to 86 with mild to moderate Alzheimer's disease and found that those who received four weekly infusions of plasma from blood donors ages 18 to 30 had significantly improved scores on daily living skill tests, similar cognition and no serious adverse effects, compared with those who received a saline placebo. The study, presented at the Clinical Trials on Alzheimer's Disease meeting, suggests that younger people's plasma may have regenerative properties, but more studies are needed, said lead researcher Dr. Sharon Sha.
Patients with Alzheimer's disease may benefit from young blood
Sign up for SNMMI SmartBrief
Nuclear medicine and molecular imaging news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.